Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.75 and traded as high as $5.55. AIkido Pharma shares last traded at $5.50, with a volume of 238,632 shares changing hands.
AIkido Pharma Stock Up 5.4%
The company’s fifty day moving average price is $5.25 and its two-hundred day moving average price is $4.75. The firm has a market cap of $30.17 million, a PE ratio of -1.42 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- The Market Rally Is Gaining Momentum—Don’t Get Left Behind
- Trading Halts Explained
- High-Flying GE Aerospace Drops After Blowout Q2 — What Now?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
